Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
710.40
584.61
499.64
621.66
656.50
298.97
Shareholder's Funds
710.40
584.61
499.64
621.66
656.50
298.97
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
13.90
8.78
13.59
6.06
6.28
7.25
Secured Loans
13.90
8.78
13.59
6.06
6.28
7.25
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
32.31
17.35
0.00
0.00
0.00
0.00
Other Long Term Liabilities
76.68
84.43
71.86
65.47
57.09
6.6
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
77.68
85.43
72.86
66.47
57.09
6.60
Current Liabilities
Trade Payables
27.51
33.12
26.60
27.38
13.51
15.57
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
122.34
110.31
91.48
89.20
54.87
39.08
Total Liabilities
910.43
780.35
663.98
777.33
768.46
344.65
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
200.30
204.46
194.97
178.61
119.49
23.73
Less: Accumulated Depreciation
36.02
27.91
16.72
8.69
5.58
4.50
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
164.28
176.54
178.25
169.92
113.92
19.23
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
6.36
66.43
6.43
97.67
5.53
5.45
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.37
0.27
0.19
1.78
12.92
3.48
Total Non-Current Assets
453.41
472.50
184.87
269.38
132.36
28.16
Current Assets Loans & Advances
Current Investments
208.09
164.98
240.11
426.18
562.11
293.11
Inventories
51.52
10.37
0.00
0.00
0.00
0.00
Sundry Debtors
69.34
0.15
0.00
0.00
0.00
0.00
Cash and Bank
115.69
114.89
231.73
78.23
67.33
13.97
Other Current Assets
444.64
290.39
471.85
504.41
629.44
307.08
Short Term Loans and Advances
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Assets
457.02
307.85
479.12
507.96
636.10
316.49
Net Current Assets (Including Current Investments)
334.68
197.54
387.63
418.76
581.23
277.41
Total Current Assets Excluding Current Investments
457.02
307.85
479.12
507.96
636.10
316.49
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
910.43
780.35
663.98
777.33
768.46
344.65
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
13.90
8.78
13.59
6.06
6.28
7.25
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
Compare Balance Sheet Results of Iovance Biotherapeutics, Inc.
Figures in Million
Consolidated - Balance Sheet Results
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
710.40
472.69
237.71
50.29%
Shareholder's Funds
710.40
472.69
237.71
50.29%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
13.90
14.80
-0.90
-6.08%
Secured Loans
13.90
14.80
-0.90
-6.08%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
32.31
0
32.31
0.00%
Other Long Term Liabilities
76.68
70.63
6.05
8.57%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
77.68
70.63
7.05
9.98%
Current Liabilities
Trade Payables
27.51
1.63
25.88
1,587.73%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
122.34
71.01
51.33
72.29%
Total Liabilities
910.43
614.32
296.11
48.20%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
200.30
236.99
-36.69
-15.48%
Less: Accumulated Depreciation
36.02
75.64
-39.62
-52.38%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
164.28
161.35
2.93
1.82%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
6.36
4.34
2.02
46.54%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
0.37
1.57
-1.20
-76.43%
Total Non-Current Assets
453.41
267.55
185.86
69.47%
Current Assets Loans & Advances
Current Investments
208.09
50.08
158.01
315.52%
Inventories
51.52
24.08
27.44
113.95%
Sundry Debtors
69.34
34.90
34.44
98.68%
Cash and Bank
115.69
226.32
-110.63
-48.88%
Other Current Assets
444.64
335.38
109.26
32.58%
Short Term Loans and Advances
0
0
0.00
0.00%
Total Current Assets
457.02
346.78
110.24
31.79%
Net Current Assets (Including Current Investments)
334.68
275.77
58.91
21.36%
Total Current Assets Excluding Current Investments
457.02
346.78
110.24
31.79%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
910.43
614.32
296.11
48.20%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
13.90
14.80
-0.90
-6.08%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Analysis not available as Data has been published for only 1 period
Annual - Other Long Term Liabilities
Analysis not available as Data has been published for only 1 period
Annual - Fixed Assets
Analysis not available as Data has been published for only 1 period
Annual - Investments
Analysis not available as Data has been published for only 1 period
Annual - Current Assets
Analysis not available as Data has been published for only 1 period






